Data will drop in its own good time. The only thing the company can do is not declare when readouts are expected since this is totally beyond their control (and often a source of shareholder angst).
I would like to see a breakdown of the corporate and admin expenses. 1.2 mil seems a bit steep for a company this size.
The quality of the final data from Kazia's in-house p2 trial will probably determine whether it's a CR next year or a partnering deal.
KZA Price at posting:
$1.50 Sentiment: None Disclosure: Held
